Levels of CD105+ cells increase and cell proliferation decreases during S‑phase arrest of amniotic fluid cells in long‑term culture

Wang,Ding; Chen,Rui; Zhong,Xuan; Fan,Yong; Lai,Weiqiang; Sun,Xiaofang

doi:10.3892/etm.2014.1959

Levels of CD105+ cells increase and cell proliferation decreases during S‑phase arrest of amniotic fluid cells in long‑term culture

Authors:
- Ding Wang
- Rui Chen
- Xuan Zhong
- Yong Fan
- Weiqiang Lai
- Xiaofang Sun
View Affiliations

Affiliations: Key Laboratory for Major Obstetric Diseases of Guangdong Province, Guangdong Higher Education Institutes, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510150, P.R. China
Published online on: September 12, 2014 https://doi.org/10.3892/etm.2014.1959
Pages: 1604-1610

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to improve the characterization of amniotic fluid cells (AFCs) in order to optimize their use in chromosomal prenatal diagnosis and as seed or stem cells for tissue engineering. The AFCs used in the current study were obtained from three females in their second trimester of pregnancy. The cells were cultured independently and characterized by cell morphology, cell markers, cell cycle distribution and chromosome Giemsa banding in an early‑ and late‑passage. The AFCs remained homogeneous in culture and expressed mesenchymal markers, but not endothelial markers along the culture process. In addition, compared with the early-passage cells, the late-passage cells exhibit an increase in CD105 expression, a decrease in cell division and a delay in the cell cycle, and a number of cells underwent cell cycle arrest. However, the cells retained a normal karyotype. Therefore, the current study characterized AFCs in a clinical culture and confirmed that AFCs are mesenchymal precursors. The results obtained may be useful for the application of AFCs in prenatal diagnosis.

View Figures

View References

1	Priest RE, Marimuthu KM and Priest JH: Origin of cells in human amniotic fluid cultures: ultrastructural features. Lab Invest. 39:106–109. 1978.PubMed/NCBI
2	Macek M, Hurych J, Hyánek J, et al: Cultivation of amniotic fluid cells and prenatal diagnosis. Cesk Gynekol. 36:556–558. 1971.(In Czech).
3	Mulcahy MT and Jenkyn J: Prenatal diagnosis. Results of cytogenetic analysis of amniotic fluid cell cultures. Med J Aust. 1:979–982. 1973.PubMed/NCBI
4	Macek M, Suk V, Bresták M, Rezácová D, Houstĕk J and Kotásek A: Cultivation of cells from amniotic fluid for prenatal diagnosis. Cesk Pediatr. 29:87–89. 1974.(In Czech).
5	Zolotukhina TV: Amniotic fluid cell culture for the prenatal diagnosis of the fetal karyotype. Tsitol Genet. 14:57–63. 1980.(In Russian).
6	Lapierre JM, Cacheux V, Collot N, et al: Comparison of comparative genomic hybridization with conventional karyotype and classical fluorescence in situ hybridization for prenatal and postnatal diagnosis of unbalanced chromosome abnormalities. Ann Genet. 41:133–140. 1998.
7	Guven MA, Ceylaner G and Coskun A: Volume of sampled amniotic fluid and prenatal cytogenetic diagnosis. Int J Gynaecol Obstet. 95:157–158. 2006. View Article : Google Scholar : PubMed/NCBI
8	Rebello MT, Hackett G, Smith J, et al: Extraction of DNA from amniotic fluid cells for the early prenatal diagnosis of genetic disease. Prenat Diagn. 11:41–46. 1991. View Article : Google Scholar : PubMed/NCBI
9	Polgár K, Adány R, Abel G, Kappelmayer J, Muszbek L and Papp Z: Characterization of rapidly adhering amniotic fluid cells by combined immunofluorescence and phagocytosis assays. Am J Hum Genet. 45:786–792. 1989.PubMed/NCBI
10	In ‘t Anker PS, Scherjon SA, Kleijburg-van der Keur C, et al: Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood. 102:1548–1549. 2003.PubMed/NCBI
11	De Coppi P, Bartsch G Jr, Siddiqui MM, et al: Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol. 25:100–106. 2007.PubMed/NCBI
12	Li C, Zhou J, Shi G, et al: Pluripotency can be rapidly and efficiently induced in human amniotic fluid-derived cells. Hum Mol Genet. 18:4340–4349. 2009. View Article : Google Scholar : PubMed/NCBI
13	Fan Y, Luo Y, Chen X, Li Q and Sun X: Generation of human β-thalassemia induced pluripotent stem cells from amniotic fluid cells using a single excisable lentiviral stem cell cassette. J Reprod Dev. 58:404–409. 2012.
14	Li Q, Fan Y, Sun X and Yu Y: Generation of induced pluripotent stem cells from human amniotic fluid cells by reprogramming with two factors in feeder-free conditions. J Reprod Dev. 59:72–77. 2013.PubMed/NCBI
15	Mirabella T, Cilli M, Carlone S, Cancedda R and Gentili C: Amniotic liquid derived stem cells as reservoir of secreted angiogenic factors capable of stimulating neo-arteriogenesis in an ischemic model. Biomaterials. 32:3689–3699. 2011. View Article : Google Scholar : PubMed/NCBI
16	Mirabella T, Poggi A, Scaranari M, et al: Recruitment of host’s progenitor cells to sites of human amniotic fluid stem cells implantation. Biomaterials. 32:4218–4227. 2011.
17	Lu HE, Yang YC, Chen SM, et al: Modeling neurogenesis impairment in Down syndrome with induced pluripotent stem cells from trisomy 21 amniotic fluid cells. Exp Cell Res. 319:498–505. 2013. View Article : Google Scholar : PubMed/NCBI
18	Hoehn H, Bryant EM, Karp LE and Martin GM: Cultivated cells from diagnostic amniocentesis in second trimester pregnancies. I Clonal morphology and growth potential. Pediatr Res. 8:746–754. 1974. View Article : Google Scholar : PubMed/NCBI
19	Hoehn H, Bryant EM, Fantel AG and Martin GM: Cultivated cells from diagnostic amniocentesis in second trimester pregnancies. III The fetal urine as a potential source of clonable cells. Humangenetik. 29:285–290. 1975.PubMed/NCBI
20	Hoehn H, Bryant EM, Karp LE and Martin GM: Cultivated cells from diagnostic amniocentesis in second trimester pregnancies. II Cytogenetic parameters as functions of clonal type and preparative technique. Clin Genet. 7:29–36. 1975. View Article : Google Scholar : PubMed/NCBI
21	Davydova DA, Vorotelyak EA, Smirnova YA, et al: Cell phenotypes in human amniotic fluid. Acta Naturae. 1:98–103. 2009.PubMed/NCBI
22	Cananzi M and De Coppi P: CD117(+) amniotic fluid stem cells: state of the art and future perspectives. Organogenesis. 8:77–88. 2012. View Article : Google Scholar : PubMed/NCBI
23	Bossolasco P, Montemurro T, Cova L, et al: Molecular and phenotypic characterization of human amniotic fluid cells and their differentiation potential. Cell Res. 16:329–336. 2006. View Article : Google Scholar : PubMed/NCBI